---
name: manuscript-review
description: |
  æ¨¡æ“¬åŒè¡Œå¯©ç¨¿èˆ‡å ±å‘ŠæŒ‡å¼•åˆè¦æ€§æª¢æŸ¥æ¡†æ¶ã€‚
  LOAD THIS SKILL WHEN: peer reviewã€åŒè¡Œå¯©æŸ¥ã€reviewerã€å¯©ç¨¿ã€reporting guidelinesã€CONSORTã€STROBEã€PRISMAã€CAREã€critiqueã€æª¢æŸ¥ç¨¿ä»¶ã€ç¨¿ä»¶å•é¡Œ
  CAPABILITIES: ç´”æŒ‡ä»¤æŠ€èƒ½ï¼Œæ­é… read_draft MCP tool è®€å–è‰ç¨¿å…§å®¹ã€‚LLM ç”¨é†«å­¸çŸ¥è­˜åšå¯©æŸ¥ï¼Œæ¯” regex æ›´æº–ç¢ºã€‚
---

# ç¨¿ä»¶å¯©æŸ¥èˆ‡å ±å‘ŠæŒ‡å¼•æŠ€èƒ½

LLM èªæ„ç†è§£ > regex é—œéµå­—åŒ¹é…ã€‚è³‡æ–™ç”¨ `read_draft` MCP toolï¼Œå¯©æŸ¥é‚è¼¯ç”± LLM + domain knowledgeã€‚

è§¸ç™¼ï¼šå¯©æŸ¥è‰ç¨¿ã€reviewerã€CONSORTã€STROBEã€PRISMAã€CAREã€æŠ•ç¨¿å‰æª¢æŸ¥

## æ­é… MCP Tools

| å·¥å…·               | ç”¨é€”                            |
| ------------------ | ------------------------------- |
| `read_draft`       | **å¿…ç”¨** â€” è®€è‰ç¨¿               |
| `list_drafts`      | åˆ—å‡ºå¯å¯©æŸ¥çš„è‰ç¨¿                |
| `count_words`      | å­—æ•¸çµ±è¨ˆ                        |
| `check_formatting` | æœŸåˆŠæ ¼å¼é‡åŒ–æª¢æŸ¥ + è·¨æ–‡ä»¶ä¸€è‡´æ€§ |

---

## Framework 1: Peer Review

ç”¨ `read_draft` å–å¾—å…§å®¹ â†’ æŒ‰ 4 é¢å‘å¯©æŸ¥ â†’ è¼¸å‡ºçµæ§‹åŒ–å ±å‘Š

### å¯©æŸ¥é¢å‘

**1. Structure**ï¼šå¿…è¦ç« ç¯€é½Šå…¨ã€Abstract çµæ§‹åŒ–ã€é‚è¼¯é †åºï¼ˆMajor if ç¼ºå°‘/äº‚åºï¼‰

**2. Methods**ï¼š
| é …ç›® | Major/Minor |
|------|-------------|
| Ethics/IRB statement | Major |
| Statistical methods | Major |
| Sample size justification | Minor |
| Primary outcome definition | Minor |
| Inclusion/exclusion criteria | Minor |

**3. Statistics**ï¼š
| é …ç›® | Major/Minor |
|------|-------------|
| Confidence intervals | Major |
| P-value reporting (ç²¾ç¢ºå€¼) | Minor |
| Multiple comparisons correction | Minor |
| Effect size | Minor |

**4. Writing**ï¼š
| é …ç›® | Major/Minor |
|------|-------------|
| Limitations section | Major |
| Causal language in observational | Major |
| Word count / Reference density | Minor |

### åˆ¤å®š

Major â‰¥3 â†’ ğŸ”´ Major revision required | 1-2 â†’ ğŸŸ¡ Major revision | 0 â†’ âœ… Minor/Accept

---

## Framework 2: Reporting Guideline Compliance

`read_draft` â†’ è‡ªå‹•åµæ¸¬/æŒ‡å®š guideline â†’ é€é …æª¢æŸ¥ â†’ åˆè¦å ±å‘Š

### Auto-Detection

| è‰ç¨¿ç‰¹å¾µ                            | æŒ‡å¼•    |
| ----------------------------------- | ------- |
| randomized, RCT, blinded, placebo   | CONSORT |
| systematic review, meta-analysis    | PRISMA  |
| case report, case presentation      | CARE    |
| observational, cohort, case-control | STROBE  |

### CONSORT (RCT, 21 items)

Title(1), Abstract(2), Intro(3-4: background, objectives), Methods(5-13: design, eligibility, interventions, outcomes, sample size, randomization, allocation concealment, blinding, statistics), Results(14-19: flow, recruitment, baseline, N analysed, outcomes+CI, harms), Discussion(20: interpretation+limitations), Other(21: registration)

### STROBE (Observational, 16 items)

Title(1), Intro(2-3), Methods(4-11: design, setting, participants, variables, measurement, bias, sample size, statistics), Results(12-14: participants, descriptive, outcome), Discussion(15: interpretation), Other(16: funding)

### PRISMA (SR, 17 items)

Title(1), Abstract(2), Intro(3), Methods(4-11: protocol, eligibility, sources, strategy, selection, extraction, RoB, synthesis), Results(12-15: flow, characteristics, results, heterogeneity), Discussion(16), Other(17: registration)

### CARE (Case Report, 13 items)

Title(1), Abstract(2), Intro(3), Patient(4-7: demographics, complaints, history, exam), Clinical(8-10: diagnosis, intervention, follow-up), Discussion(11-12: strengths/limits, rationale), Patient(13: consent)

### åˆ¤å®š

â‰¥80% â†’ ğŸŸ¢ Good | 60-80% â†’ ğŸŸ¡ Needs attention | <60% â†’ ğŸ”´ Significant gaps

---

## ä½¿ç”¨åŸå‰‡

1. èªæ„ç†è§£ï¼Œéé—œéµå­—åŒ¹é…ï¼ˆã€Œå€«ç†å§”å“¡æœƒæ ¸å‡†ã€= ethics approvalï¼‰
2. Major = å¯èƒ½è¢« rejectï¼ŒMinor = æ”¹å–„å»ºè­°
3. çµ¦å…·é«”ä¿®å¾©å»ºè­°
4. å¤šæª”æ¡ˆæ”¯æŒï¼ˆIntroductionã€Methods å¯èƒ½åœ¨ä¸åŒæª”æ¡ˆï¼‰
